Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Launch date8 April 2026 (video publication date; already published)
Relationship between the counterparty and the company
Kringle Pharma,Inc.4884
Relationship with the Company
Participation in the IR seminar
CounterpartyNihon Securities Shimbun
Organizer of the IR seminar for individual investors. Other details: Not disclosed
Location (as indicated in this announcement)
Tokyo Stock Exchange Building, 8th-floor hall (seminar venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Source (materials cited by the company)
Official Nihon Securities Journal channel
| Item | Details |
|---|---|
| Counterparty | Nihon Securities Shimbun |
| Counterparty overview | Organizer of the IR seminar for individual investors. Other details: Not disclosed |
| Relationship with the Company | Participation in the IR seminar |
| Launch date | 8 April 2026 (video publication date; already published) |
| Location | Tokyo Stock Exchange Building, 8th-floor hall (seminar venue) |
| Source | Official Nihon Securities Journal channel |
Items this document does not state (12)
Names of Products / Services CoveredContract ValueOffering priceContract DateApplicable areaAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To deepen investors’ understanding and help them make investment decisions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.